Cetera Investment Advisers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $736K | Sell |
|
|||||
|
2025
Q1 | $1.45M | Buy |
|
|||||
|
2024
Q4 | $1.66M | Sell |
|
|||||
|
2024
Q3 | $1.99M | Buy |
|
|||||
|
2024
Q2 | $2.06M | Buy |
|
|||||
|
2024
Q1 | $2.64M | Buy |
|
|||||
|
2023
Q4 | $712K | Buy |
|
|||||
|
2023
Q3 | $551K | Buy |
|
|||||
|
2023
Q2 | $587K | Buy |
|
|||||
|
2023
Q1 | $363K | Sell |
|
|||||
|
2022
Q4 | $410K | Buy |
|
|||||
|
2022
Q3 | $268K | Sell |
|
|||||
|
2022
Q2 | $316K | Buy |
|
|||||
|
2022
Q1 | $404K | Sell |
|
|||||
|
2021
Q4 | $992K | Sell |
|
|||||
|
2021
Q3 | $1.18M | Sell |
|
|||||
|
2021
Q2 | $1.06M | Buy |
|
|||||
|
2021
Q1 | $519K | Buy |
|
|||||
|
2020
Q4 | $432K | Buy |
|